T helper cells that produce interleukin 17 (IL-17) are associated with inflammation and the control of certain bacteria. We report here the essential involvement of the adaptor protein Act1 in IL-17 receptor (IL-17R) signaling and IL-17-dependent immune responses. After stimulation with IL-17, recruitment of Act1 to IL-17R required the IL-17R conserved cytoplasmic 'SEFIR' domain, followed by recruitment of the kinase TAK1 and E3 ubiquitin ligase TRAF6, which mediate 'downstream' activation of transcription factor NF-kappaB. IL-17-induced expression of inflammation-related genes was abolished in Act1-deficient primary astroglial and gut epithelial cells. This reduction was associated with much less inflammatory disease in vivo in both autoimmune encephalomyelitis and dextran sodium sulfate-induced colitis. Our data show that Act1 is essential in IL-17-dependent signaling in autoimmune and inflammatory disease.
SUMMARY
Interleukin-17 (IL-17) secreted by T helper 17 (Th17) cells is essential in the development of experimental autoimmune encephalomyelitis (EAE). However, it remains unclear how IL-17-mediated signaling in different cellular compartments participates in the central nervous system (CNS) inflammatory process. We examined CNS inflammation in mice with specific deletion of Act1, a critical component required for IL-17 signaling, in endothelial cells, macrophages and microglia, and neuroectoderm (neurons, astrocytes, and oligodendrocytes). In Act1-deficient mice, Th17 cells showed normal infiltration into the CNS but failed to recruit lymphocytes, neutrophils, and macrophages. Act1 deficiency in endothelial cells or in macrophages and microglia did not substantially impact the development of EAE. However, targeted Act1 deficiency in neuroectoderm derived CNS resident cells resulted in markedly reduced severity in EAE. Specifically, Act1-deficient astrocytes showed impaired IL-17-mediated inflammatory gene induction. Thus, astroctyes are critical in IL-17-Act1 mediated leukocyte recruitment during autoimmune induced inflammation of the CNS.
Interleukin (IL)-17, a proinflammatory cytokine mainly produced by T-helper-17 (T H 17) lineage, is required for host defense against bacteria and fungus infection and plays a critical role in the pathogenesis of inflammatory and autoimmune diseases. Act1 is an essential adaptor molecule in IL-17-mediated signaling pathway, recruited to IL-17 receptor (IL-17R) upon IL-17 stimulation through SEFIR-SEFIR domain interaction. Here we report that Act1 is a novel bona fide U-box E3 ubiquitin ligase, whose activity is essential for IL-17-mediated signaling pathways (including nuclear factor kappa B (NFκB), and partially required for Jun N-terminal Kinase (JNK) and extracellular signal-regulated kinase (ERK) activation) and inflammatory gene expression (KC (CXCL1), granulocyte macrophage colony stimulating factor (GM-CFS ) and IL-6) in mammalian cells. By utilizing Ubc13/Uev1A E2 complex, Act1 mediates Lys 63-linked ubiquitination of tumor necrosis factor receptor-associated factor 6 (TRAF6), an important signaling component of IL-17-mediated signaling pathway. Deletion and point mutations of the Act1 U-box abolish Act1-mediated ubiquitination of TRAF6 and impair the ability of Act1 to restore IL-17-dependent signaling and inflammatory gene expression in Act1 −/− mouse embryonic fibroblasts (MEFs). Importantly, we demonstrate that the Lys 124 residue of TRAF6 is critical for efficient Act1-mediated TRAF6 ubiquitination and for the ability of TRAF6 to mediate IL-17-induced NFκB activation. Thus Act1 mediates IL-17-induced signaling pathways through its E3 ubiquitin ligase activity and TRAF6 is a critical substrate of Act1, indicating the importance of protein ubiquitination in IL-17-dependent inflammatory response.
Transgenic expression of TLR7 results in the expansion and hyperactivation of T1 B cells in response to endogenous RNA complexes, leading to increased autoantibody production.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.